| 1 |
Liu W, Yasui M, Sassa A, You X, Wan J, Cao Y, Xi J, Zhang X, Honma M, Luan Y. FTO regulates the DNA damage response via effects on cell-cycle progression. Mutation Research/Genetic Toxicology and Environmental Mutagenesis 2023;887:503608. [DOI: 10.1016/j.mrgentox.2023.503608] [Reference Citation Analysis]
|
| 2 |
Fischer GM, Lindeman NI, Ligon AH, Russell-Goldman E. Proliferating Pilar Tumors Are Characterized by Recurrent 15q, 6q, and 6p22.2 Alterations. Am J Dermatopathol 2023;45:217-26. [PMID: 36346171 DOI: 10.1097/DAD.0000000000002308] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 3 |
Morgado-Palacin L, Brown JA, Martinez TF, Garcia-Pedrero JM, Forouhar F, Quinn SA, Reglero C, Vaughan J, Heydary YH, Donaldson C, Rodriguez-Perales S, Allonca E, Granda-Diaz R, Fernandez AF, Fraga MF, Kim AL, Santos-Juanes J, Owens DM, Rodrigo JP, Saghatelian A, Ferrando AA. The TINCR ubiquitin-like microprotein is a tumor suppressor in squamous cell carcinoma. Nat Commun 2023;14:1328. [PMID: 36899004 DOI: 10.1038/s41467-023-36713-8] [Reference Citation Analysis]
|
| 4 |
Bii VM, Rudoy D, Klezovitch O, Vasioukhin V. Lethal giant larvae gene family (Llgl1andLlgl2) functions as a tumor suppressor in mouse skin epidermis.. [DOI: 10.1101/2023.03.06.531408] [Reference Citation Analysis]
|
| 5 |
Grant SR, Rosario SR, Patentreger AD, Shary N, Fitzgerald ME, Singh PK, Foster BA, Huss WJ, Wei L, Paragh G. HotSPOT: A Computational Tool to Design Targeted Sequencing Panels to Assess Early Photocarcinogenesis. Cancers (Basel) 2023;15. [PMID: 36900402 DOI: 10.3390/cancers15051612] [Reference Citation Analysis]
|
| 6 |
Nappi A, Miro C, Pezone A, Tramontano A, Di Cicco E, Sagliocchi S, Cicatiello AG, Murolo M, Torabinejad S, Abbotto E, Caiazzo G, Raia M, Stornaiuolo M, Antonini D, Fabbrocini G, Salvatore D, Avvedimento VE, Dentice M. Loss of p53 activates thyroid hormone via type 2 deiodinase and enhances DNA damage. Nat Commun 2023;14:1244. [PMID: 36871014 DOI: 10.1038/s41467-023-36755-y] [Reference Citation Analysis]
|
| 7 |
Shea LK, Akhave NS, Sutton LA, Compton LA, York C, Ramakrishnan SM, Miller CA, Wartman LD, Chen DY. Combined Kdm6a and Trp53 Deficiency Drives the Development of Squamous Cell Skin Cancer in Mice. J Invest Dermatol 2023;143:232-241.e6. [PMID: 36055401 DOI: 10.1016/j.jid.2022.08.037] [Reference Citation Analysis]
|
| 8 |
Kumah E, Bibee K. Modelling cutaneous squamous cell carcinoma for laboratory research. Exp Dermatol 2023;32:117-25. [PMID: 36373888 DOI: 10.1111/exd.14706] [Reference Citation Analysis]
|
| 9 |
Pancotti C, Rollo C, Birolo G, Benevenuta S, Fariselli P, Sanavia T. Unravelling the instability of mutational signatures extraction via archetypal analysis. Front Genet 2022;13:1049501. [PMID: 36685831 DOI: 10.3389/fgene.2022.1049501] [Reference Citation Analysis]
|
| 10 |
Chong CY, Goh MS, Porceddu SV, Rischin D, Lim AM. The Current Treatment Landscape of Cutaneous Squamous Cell Carcinoma. Am J Clin Dermatol 2023;24:25-40. [PMID: 36512176 DOI: 10.1007/s40257-022-00742-8] [Reference Citation Analysis]
|
| 11 |
Zhao C, Xiong K, Bi D, Zhao F, Lan Y, Jin X, Li X. Redox-associated messenger RNAs identify novel prognostic values and influence the tumor immune microenvironment of lung adenocarcinoma. Front Genet 2023;14:1079035. [PMID: 36873939 DOI: 10.3389/fgene.2023.1079035] [Reference Citation Analysis]
|
| 12 |
Zou D, Sun Y, Li X, Wu W, Xu D, He Y, Qi J, Tu Y, Tang Y, Tu Y, Wang X, Li X, Lu F, Huang L, Long H, He L, Li X. Single-cell Sequencing Highlights Heterogeneity and Malignant Progression in Actinic Keratosis and Cutaneous Squamous Cell Carcinoma.. [DOI: 10.1101/2022.12.22.521622] [Reference Citation Analysis]
|
| 13 |
Grant SR, Rosario SR, Patentreger AD, Shary N, Fitzgerald ME, Singh PK, Foster BA, Huss WJ, Wei L, Paragh G. HotSPOT: a computational tool to design targeted sequencing panels to assess early photocarcinogenesis.. [DOI: 10.21203/rs.3.rs-2216887/v1] [Reference Citation Analysis]
|
| 14 |
Bottomley MJ, Massey PR, Thuraisingham R, Doyle A, Rao S, Bibee KP, Bouwes Bavinck JN, Jambusaria-Pahlajani A, Harwood CA. Interventions After First Post-Transplant Cutaneous Squamous Cell Carcinoma: A Proposed Decision Framework. Transpl Int 2022;35:10880. [PMID: 36484063 DOI: 10.3389/ti.2022.10880] [Reference Citation Analysis]
|
| 15 |
Matera MG, Rogliani P, Bianco A, Cazzola M. Biological and immunosuppressive therapies for lung disease: a potential reciprocal influence between their use and malignancy. Lung Diseases and Cancer 2022. [DOI: 10.1183/2312508x.10020621] [Reference Citation Analysis]
|
| 16 |
Fang H, Yan HHN, Bilardi RA, Flensburg C, Yang H, Barbour JA, Siu HC, Turski M, Chew E, Xu Z, Lam ST, Sharma R, Xu M, Li J, Ip HW, Cheung CYM, Huen MSY, Sweet-Cordero EA, Majewski IJ, Leung SY, Wong JWH. Ganciclovir-induced mutations are present in a diverse spectrum of post-transplant malignancies. Genome Med 2022;14:124. [PMID: 36316687 DOI: 10.1186/s13073-022-01131-w] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 17 |
Button R, Harwood C, O’shaughnessy R. Phosphoproteomic analysis of the AKT signalling axis in cutaneous squamous carcinoma progression reveals novel therapeutic targets.. [DOI: 10.1101/2022.10.03.510591] [Reference Citation Analysis]
|
| 18 |
Kitrell BM, Blue ED, Siller A, Lobl MB, Evans TD, Whitley MJ, Wysong A. Gene Expression Profiles in Cutaneous Oncology. Dermatologic Clinics 2022. [DOI: 10.1016/j.det.2022.07.018] [Reference Citation Analysis]
|
| 19 |
Su W, Huang B, Zhang Q, Han W, An L, Guan Y, Ji J, Yu D. Exploring Potential Biomarkers, Ferroptosis Mechanisms, and Therapeutic Targets Associated with Cutaneous Squamous Cell Carcinoma via Integrated Transcriptomic Analysis. Journal of Healthcare Engineering 2022;2022:1-14. [DOI: 10.1155/2022/3524022] [Reference Citation Analysis]
|
| 20 |
Megquier K, Turner-Maier J, Morrill K, Li X, Johnson J, Karlsson EK, London CA, Gardner HL. The genomic landscape of canine osteosarcoma cell lines reveals conserved structural complexity and pathway alterations. PLoS One 2022;17:e0274383. [PMID: 36099278 DOI: 10.1371/journal.pone.0274383] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 21 |
Hooper PB, Farberg AS, Fitzgerald AL, Siegel JJ, Rackley BB, Prasai A, Kurley SJ, Goldberg MS, Litchman GH. Real-world Evidence Shows Clinicians Appropriately Use the Prognostic 40-gene Expression Profile (40-GEP) Test for High-risk Cutaneous Squamous Cell Carcinoma (cSCC) Patients. Cancer Invest 2022;:1-14. [PMID: 36073945 DOI: 10.1080/07357907.2022.2116454] [Reference Citation Analysis]
|
| 22 |
Srivastava A, Tommasi C, Sessions D, Mah A, Bencomo T, Garcia JM, Jiang T, Lee M, Shen JY, Seow LW, Nguyen A, Rajapakshe K, Coarfa C, Tsai KY, Lopez-Pajares V, Lee CS. MAB21L4 Deficiency Drives Squamous Cell Carcinoma via Activation of RET. Cancer Res 2022;82:3143-57. [PMID: 35705526 DOI: 10.1158/0008-5472.CAN-22-0047] [Reference Citation Analysis]
|
| 23 |
Gürsel Ürün Y. Molecular Genetic Mechanisms in Cancers of Keratinocytic Origin. Molecular Mechanisms in Cancer 2022. [DOI: 10.5772/intechopen.103134] [Reference Citation Analysis]
|
| 24 |
Zhao Y, Dong J, Liao Y, Wang H, Zhou D, Kang J, Chen X. Identification and validation of four photodynamic therapy related genes inhibiting MAPK and inducing cell cycle alteration in squamous cell carcinoma. Front Oncol 2022;12:946493. [DOI: 10.3389/fonc.2022.946493] [Reference Citation Analysis]
|
| 25 |
Thind AS, Ashford B, Strbenac D, Mitchell J, Lee J, Mueller SA, Minaei E, Perry JR, Ch’ng S, Iyer NG, Clark JR, Gupta R, Ranson M. Whole genome analysis reveals the genomic complexity in metastatic cutaneous squamous cell carcinoma. Front Oncol 2022;12:919118. [DOI: 10.3389/fonc.2022.919118] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 26 |
Ansary TM, Hossain MR, Komine M, Ohtsuki M. Immunotherapy for the Treatment of Squamous Cell Carcinoma: Potential Benefits and Challenges. IJMS 2022;23:8530. [DOI: 10.3390/ijms23158530] [Reference Citation Analysis]
|
| 27 |
Olafsson S, Rodriguez E, Lawson AR, Abascal F, Jones PH, Gerdes S, Martincorena I, Weidinger S, Campbell PJ, Anderson CA. Effects of psoriasis and psoralen exposure on the somatic mutation landscape of the skin.. [DOI: 10.1101/2022.07.04.22277086] [Reference Citation Analysis]
|
| 28 |
Quadri M, Marconi A, Sandhu SK, Kiss A, Efimova T, Palazzo E. Investigating Cutaneous Squamous Cell Carcinoma in vitro and in vivo: Novel 3D Tools and Animal Models. Front Med (Lausanne) 2022;9:875517. [PMID: 35646967 DOI: 10.3389/fmed.2022.875517] [Reference Citation Analysis]
|
| 29 |
Hurst CD, Cheng G, Platt FM, Alder O, Black EV, Burns JE, Brown J, Jain S, Roulson JA, Knowles MA. Molecular profile of pure squamous cell carcinoma of the bladder identifies major roles for OSMR and YAP signalling. J Pathol Clin Res 2022;8:279-93. [PMID: 35289095 DOI: 10.1002/cjp2.261] [Reference Citation Analysis]
|
| 30 |
Helbig D. Hemato-Oncological Diseases as Risk Factor for Recurrence or Metastasis of Pleomorphic Dermal Sarcoma. Front Oncol 2022;12:873771. [DOI: 10.3389/fonc.2022.873771] [Reference Citation Analysis]
|
| 31 |
Harms PW, Verhaegen ME, Hu K, Hrycaj SM, Chan MP, Liu CJ, Grachtchouk M, Patel RM, Udager AM, Dlugosz AA. Genomic evidence suggests that cutaneous neuroendocrine carcinomas can arise from squamous dysplastic precursors. Mod Pathol 2022;35:506-14. [PMID: 34593967 DOI: 10.1038/s41379-021-00928-1] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 7.0] [Reference Citation Analysis]
|
| 32 |
Kelley MB, Geddes TJ, Ochiai M, Lampl NM, Kothmann WW, Fierstein SR, Kent V, Decicco-skinner K. Loss of Tpl2 activates compensatory signaling and resistance to EGFR/MET dual inhibition in v-RAS transduced keratinocytes. PLoS ONE 2022;17:e0266017. [DOI: 10.1371/journal.pone.0266017] [Reference Citation Analysis]
|
| 33 |
Geidel G, Heidrich I, Kött J, Schneider SW, Pantel K, Gebhardt C. Emerging precision diagnostics in advanced cutaneous squamous cell carcinoma. NPJ Precis Oncol 2022;6:17. [PMID: 35322182 DOI: 10.1038/s41698-022-00261-z] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 34 |
Hedberg ML, Berry CT, Moshiri AS, Xiang Y, Yeh CJ, Attilasoy C, Capell BC, Seykora JT. Molecular Mechanisms of Cutaneous Squamous Cell Carcinoma. Int J Mol Sci 2022;23. [PMID: 35408839 DOI: 10.3390/ijms23073478] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 6.0] [Reference Citation Analysis]
|
| 35 |
Lee SY, Lee M, Yu DS, Lee YB. Identification of genetic mutations of cutaneous squamous cell carcinoma using whole exome sequencing in non-Caucasian population. Journal of Dermatological Science 2022. [DOI: 10.1016/j.jdermsci.2022.03.007] [Reference Citation Analysis]
|
| 36 |
Lobl MB, Clarey DD, Higgins S, Sutton A, Wysong A. Sequencing of cutaneous squamous cell carcinoma primary tumors and patient-matched metastases reveals ALK as a potential driver in metastases and low mutational concordance in immunocompromised patients. JID Innovations 2022. [DOI: 10.1016/j.xjidi.2022.100122] [Reference Citation Analysis]
|
| 37 |
Blue ED, Freeman SC, Lobl MB, Clarey DD, Fredrick RL, Wysong A, Whitley MJ. Cutaneous squamous cell carcinoma arising in immunosuppressed patients: a systematic review of tumor profiling studies. JID Innovations 2022. [DOI: 10.1016/j.xjidi.2022.100126] [Reference Citation Analysis]
|
| 38 |
Tham M, Stark HJ, Jauch A, Harwood C, Pavez Lorie E, Boukamp P. Adverse Effects of Vemurafenib on Skin Integrity: Hyperkeratosis and Skin Cancer Initiation Due to Altered MEK/ERK-Signaling and MMP Activity. Front Oncol 2022;12:827985. [PMID: 35174094 DOI: 10.3389/fonc.2022.827985] [Reference Citation Analysis]
|
| 39 |
Helbig D, Ziemer M, Dippel E, Erdmann M, Hillen U, Leiter U, Mentzel T, Osterhoff G, Ugurel S, Utikal J, von Bubnoff D, Weishaupt C, Grabbe S. S1-Leitlinie Atypisches Fibroxanthom (AFX) und pleomorphes dermales Sarkom (PDS). J Dtsch Dermatol Ges 2022;20:235-45. [PMID: 35146874 DOI: 10.1111/ddg.14700_g] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
|
| 40 |
Brady SW, Gout AM, Zhang J. Therapeutic and prognostic insights from the analysis of cancer mutational signatures. Trends Genet 2022;38:194-208. [PMID: 34483003 DOI: 10.1016/j.tig.2021.08.007] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 17.0] [Reference Citation Analysis]
|
| 41 |
Helbig D, Ziemer M, Dippel E, Erdmann M, Hillen U, Leiter U, Mentzel T, Osterhoff G, Ugurel S, Utikal J, von Bubnoff D, Weishaupt C, Grabbe S. S1-guideline atypical fibroxanthoma (AFX) and pleomorphic dermal sarcoma (PDS). J Dtsch Dermatol Ges 2022. [PMID: 35099104 DOI: 10.1111/ddg.14700] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 42 |
Chang MS, Azin M, Demehri S. Cutaneous Squamous Cell Carcinoma: The Frontier of Cancer Immunoprevention. Annu Rev Pathol 2022;17:101-19. [PMID: 35073167 DOI: 10.1146/annurev-pathol-042320-120056] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 43 |
Stanganelli I, Spagnolo F, Argenziano G, Ascierto PA, Bassetto F, Bossi P, Donato V, Massi D, Massone C, Patuzzo R, Pellacani G, Quaglino P, Queirolo P, Zalaudek I, Palmieri G; on behalf of Italian Melanoma Intergroup (IMI). The Multidisciplinary Management of Cutaneous Squamous Cell Carcinoma: A Comprehensive Review and Clinical Recommendations by a Panel of Experts. Cancers 2022;14:377. [DOI: 10.3390/cancers14020377] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
|
| 44 |
Thind AS, Ashford B, Strbenac D, Gupta R, Clark JR, Iyer NG, Mitchell J, Lee J, Mueller SA, Minaei E, Perry JR, Ranson M. Whole genome analysis reveals the genomic complexity in metastatic cutaneous squamous cell carcinoma.. [DOI: 10.1101/2022.01.10.22269035] [Reference Citation Analysis]
|
| 45 |
Farberg AS, Fitzgerald AL, Ibrahim SF, Tolkachjov SN, Soleymani T, Douglas LM, Kurley SJ, Arron ST. Current Methods and Caveats to Risk Factor Assessment in Cutaneous Squamous Cell Carcinoma (cSCC): A Narrative Review. Dermatol Ther (Heidelb) 2022. [PMID: 34994967 DOI: 10.1007/s13555-021-00673-y] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 46 |
Wang JH, D’arcy M, Barnes EL, Freedman ND, Engels EA, Song M. Associations of Inflammatory Bowel Disease and Subsequent Cancers in a Population-Based Study of Older Adults in the United States. JNCI Cancer Spectrum 2022;6:pkab096. [DOI: 10.1093/jncics/pkab096] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 47 |
Tieu J, Lester S, Raymond W, Keen H, Hill CL, Nossent J. Cancer in Anti-Neutrophil Cytoplasm Antibody-Associated Vasculitis and Polyarteritis Nodosa in Australia: A Population-Based Study. ACR Open Rheumatol 2021. [PMID: 34877820 DOI: 10.1002/acr2.11378] [Reference Citation Analysis]
|
| 48 |
Kaufmann R. PD-1 - blockade in advanced cutaneous squamous cell carcinoma - fresh breeze in a deadly lull. J Eur Acad Dermatol Venereol 2022;36 Suppl 1:3-5. [PMID: 34855247 DOI: 10.1111/jdv.17398] [Reference Citation Analysis]
|
| 49 |
Tamas T, Baciut M, Nutu A, Bran S, Armencea G, Stoia S, Manea A, Crisan L, Opris H, Onisor F, Baciut G, Crisan B, Opris D, Bumbu B, Tamas A, Dinu C. Is miRNA Regulation the Key to Controlling Non-Melanoma Skin Cancer Evolution? Genes (Basel) 2021;12:1929. [PMID: 34946878 DOI: 10.3390/genes12121929] [Reference Citation Analysis]
|
| 50 |
Zou DD, Xu D, Deng YY, Wu WJ, Zhang J, Huang L, He L. Identification of key genes in cutaneous squamous cell carcinoma: a transcriptome sequencing and bioinformatics profiling study. Ann Transl Med 2021;9:1497. [PMID: 34805359 DOI: 10.21037/atm-21-3915] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
|
| 51 |
Siegel JD, Bhatia A, Ko CJ, Christensen SR. Concurrent development of high-stage cutaneous squamous cell carcinoma during complete response of metastatic cutaneous squamous cell carcinoma to programmed cell death protein 1 blockade with cemiplimab. JAAD Case Rep 2021;18:23-5. [PMID: 34778502 DOI: 10.1016/j.jdcr.2021.10.009] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 52 |
Ingrasci G, Lipman ZM, Yosipovitch G. When topical therapy of atopic dermatitis fails: a guide for the clinician. Expert Rev Clin Immunol 2021;:1-12. [PMID: 34720031 DOI: 10.1080/1744666X.2021.2000390] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 53 |
Thai AA, Lim AM, Solomon BJ, Rischin D. Biology and Treatment Advances in Cutaneous Squamous Cell Carcinoma. Cancers (Basel) 2021;13:5645. [PMID: 34830796 DOI: 10.3390/cancers13225645] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 54 |
Lim HYG, Barker N. A key malignant switch in skin SCC. Nat Cancer 2021;2:1116-1118. [DOI: 10.1038/s43018-021-00278-6] [Reference Citation Analysis]
|
| 55 |
Boudra R, Woappi Y, Wang D, Xu S, Wells M, Schmults CD, Lian CG, Ramsey MR. Regulation of 5-hydroxymethylcytosine by TET2 contributes to Squamous Cell Carcinoma tumorigenesis. J Invest Dermatol 2021:S0022-202X(21)02358-7. [PMID: 34695415 DOI: 10.1016/j.jid.2021.09.026] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 56 |
García-Sancha N, Corchado-Cobos R, Bellido-Hernández L, Román-Curto C, Cardeñoso-Álvarez E, Pérez-Losada J, Orfao A, Cañueto J. Overcoming Resistance to Immunotherapy in Advanced Cutaneous Squamous Cell Carcinoma. Cancers (Basel) 2021;13:5134. [PMID: 34680282 DOI: 10.3390/cancers13205134] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 57 |
Dessinioti C, Pitoulias M, Stratigos AJ. Epidemiology of advanced cutaneous squamous cell carcinoma. J Eur Acad Dermatol Venereol 2021. [PMID: 34592000 DOI: 10.1111/jdv.17709] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
|
| 58 |
Piipponen M, Riihilä P, Nissinen L, Kähäri VM. The Role of p53 in Progression of Cutaneous Squamous Cell Carcinoma. Cancers (Basel) 2021;13:4507. [PMID: 34572732 DOI: 10.3390/cancers13184507] [Cited by in Crossref: 5] [Cited by in F6Publishing: 8] [Article Influence: 2.5] [Reference Citation Analysis]
|
| 59 |
Kim YS, Shin S, Jung SH, Park YM, Park GS, Lee SH, Chung YJ. Genomic progression of precancerous actinic keratosis to squamous cell carcinoma. J Invest Dermatol 2021:S0022-202X(21)02162-X. [PMID: 34480890 DOI: 10.1016/j.jid.2021.07.172] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
|
| 60 |
Li Mow Chee F, Beernaert B, Loftus A, Kumar Y, Griffith BGC, Wills JC, Wheeler AP, Armstrong JD, Parsons M, Leigh IM, Proby CM, von Kriegsheim A, Bickmore WA, Frame MC, Byron A. Mena regulates the LINC complex to control actin–nuclear lamina associations, trans-nuclear membrane signalling and cancer gene expression.. [DOI: 10.1101/2021.08.31.458340] [Reference Citation Analysis]
|
| 61 |
Aiderus A, Newberg JY, Guzman-Rojas L, Contreras-Sandoval AM, Meshey AL, Jones DJ, Amaya-Manzanares F, Rangel R, Ward JM, Lee SC, Ban KH, Rogers K, Rogers SM, Selvanesan L, McNoe LA, Copeland NG, Jenkins NA, Tsai KY, Black MA, Mann KM, Mann MB. Transposon mutagenesis identifies cooperating genetic drivers during keratinocyte transformation and cutaneous squamous cell carcinoma progression. PLoS Genet 2021;17:e1009094. [PMID: 34398873 DOI: 10.1371/journal.pgen.1009094] [Reference Citation Analysis]
|
| 62 |
Wang L, Xu L, Wang Y. Huaier Inhibits Proliferation, Migration, and Invasion of Cutaneous Squamous Cell Carcinoma Cells by Inhibiting the Methylation Levels of CDKN2A and TP53. Integr Cancer Ther 2021;20:15347354211031646. [PMID: 34291682 DOI: 10.1177/15347354211031646] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
|
| 63 |
Chang D, Shain AH. The landscape of driver mutations in cutaneous squamous cell carcinoma. NPJ Genom Med 2021;6:61. [PMID: 34272401 DOI: 10.1038/s41525-021-00226-4] [Cited by in Crossref: 24] [Cited by in F6Publishing: 23] [Article Influence: 12.0] [Reference Citation Analysis]
|
| 64 |
Hedberg M, Seykora JT. Clarifying Progress on the Genomic Landscape of Actinic Keratosis. J Invest Dermatol 2021;141:1622-4. [PMID: 34167719 DOI: 10.1016/j.jid.2021.02.761] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 65 |
Westphal D, Garzarolli M, Sergon M, Horak P, Hutter B, Becker JC, Wiegel M, Maczey E, Blum S, Grosche-Schlee S, Rütten A, Ugurel S, Stenzinger A, Glimm H, Aust D, Baretton G, Beissert S, Fröhling S, Redler S, Surowy H, Meier F. High tumour mutational burden and EGFR/MAPK pathway activation are therapeutic targets in metastatic porocarcinoma. Br J Dermatol 2021. [PMID: 34185311 DOI: 10.1111/bjd.20604] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 66 |
Kina S, Kawabata-Iwakawa R, Miyamoto S, Arasaki A, Sunakawa H, Kinjo T. A molecular signature of well-differentiated oral squamous cell carcinoma reveals a resistance mechanism to metronomic chemotherapy and novel therapeutic candidates. J Drug Target 2021;:1-10. [PMID: 33979258 DOI: 10.1080/1061186X.2021.1929256] [Reference Citation Analysis]
|
| 67 |
Ishiguro A, Ogata D, Namikawa K, Takahashi A, Yamazaki N. Two cases of advanced cutaneous squamous cell carcinoma lesions on the head and neck successfully treated with nivolumab. J Dermatol 2021;48:e434-5. [PMID: 34018639 DOI: 10.1111/1346-8138.15971] [Reference Citation Analysis]
|
| 68 |
Chen ZY, Zhu YH, Zhou LY, Shi WQ, Qin Z, Wu B, Yan Y, Pei YW, Chao NN, Zhang R, Wang MY, Su ZH, Lu XJ, He ZY, Xu T. Association Between Genetic Polymorphisms of Metabolic Enzymes and Azathioprine-Induced Myelosuppression in 1,419 Chinese Patients: A Retrospective Study. Front Pharmacol 2021;12:672769. [PMID: 34084143 DOI: 10.3389/fphar.2021.672769] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
|
| 69 |
Roth K, Coussement L, Knatko EV, Higgins M, Steyaert S, Proby CM, de Meyer T, Dinkova-Kostova AT. Clinically relevant aberrant Filip1l DNA methylation detected in a murine model of cutaneous squamous cell carcinoma. EBioMedicine 2021;67:103383. [PMID: 34000624 DOI: 10.1016/j.ebiom.2021.103383] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 70 |
Lichtenberger BM, Kasper M. Cellular heterogeneity and microenvironmental control of skin cancer. J Intern Med 2021;289:614-28. [PMID: 32976658 DOI: 10.1111/joim.13177] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 71 |
Polyakov AP, Gevorkov AR, Stepanova AA. Current strategy of squamous cell carcinoma diagnosis and treatment. Opuholi golovy i šei 2021;11:51-72. [DOI: 10.17650/2222-1468-2021-11-1-51-72] [Reference Citation Analysis]
|
| 72 |
Whitley MJ, Suwanpradid J, Lai C, Jiang SW, Cook JL, Zelac DE, Rudolph R, Corcoran DL, Degan S, Spasojevic I, Levinson H, Erdmann D, Reid C, Zhang JY, Robson SC, Healy E, Havran WL, MacLeod AS. ENTPD1 (CD39) Expression Inhibits UVR-Induced DNA Damage Repair through Purinergic Signaling and Is Associated with Metastasis in Human Cutaneous Squamous Cell Carcinoma. J Invest Dermatol 2021:S0022-202X(21)01118-0. [PMID: 33848530 DOI: 10.1016/j.jid.2021.02.753] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 73 |
Schäfer M, Semmler ML, Bernhardt T, Fischer T, Kakkassery V, Ramer R, Hein M, Bekeschus S, Langer P, Hinz B, Emmert S, Boeckmann L. Small Molecules in the Treatment of Squamous Cell Carcinomas: Focus on Indirubins. Cancers (Basel) 2021;13:1770. [PMID: 33917267 DOI: 10.3390/cancers13081770] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 4.0] [Reference Citation Analysis]
|
| 74 |
Kakiuchi N, Ogawa S. Clonal expansion in non-cancer tissues. Nat Rev Cancer 2021;21:239-56. [PMID: 33627798 DOI: 10.1038/s41568-021-00335-3] [Cited by in Crossref: 80] [Cited by in F6Publishing: 79] [Article Influence: 40.0] [Reference Citation Analysis]
|
| 75 |
Mannella V, Boehm K, Celik S, Ali T, Mirza AN, El Hasnaouy M, Kaffa A, Lyu Y, Kafaei Golahmadi D, Leigh IM, Bergamaschi D, Harwood CA, Maffucci T. Growth and Viability of Cutaneous Squamous Cell Carcinoma Cell Lines Display Different Sensitivities to Isoform-Specific Phosphoinositide 3-Kinase Inhibitors. Int J Mol Sci 2021;22:3567. [PMID: 33808215 DOI: 10.3390/ijms22073567] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 76 |
Díaz-Gay M, Alexandrov LB. Unraveling the genomic landscape of colorectal cancer through mutational signatures. Adv Cancer Res 2021;151:385-424. [PMID: 34148618 DOI: 10.1016/bs.acr.2021.03.003] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 77 |
Ishitsuka Y, Hanaoka Y, Tanemura A, Fujimoto M. Cutaneous Squamous Cell Carcinoma in the Age of Immunotherapy. Cancers (Basel) 2021;13:1148. [PMID: 33800195 DOI: 10.3390/cancers13051148] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 4.5] [Reference Citation Analysis]
|
| 78 |
Zhang G, Yan G, Fu Z, Wu Y, Wu F, Zheng Z, Fang S, Gao Y, Bao X, Liu Y, Wang X, Zhu S. Loss of retinoic acid receptor-related receptor alpha (Rorα) promotes the progression of UV-induced cSCC. Cell Death Dis 2021;12:247. [PMID: 33664254 DOI: 10.1038/s41419-021-03525-x] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 79 |
Hernando B, Dietzen M, Parra G, Gil-Barrachina M, Pitarch G, Mahiques L, Valcuende-Cavero F, McGranahan N, Martinez-Cadenas C. The effect of age on the acquisition and selection of cancer driver mutations in sun-exposed normal skin. Ann Oncol 2021;32:412-21. [PMID: 33307203 DOI: 10.1016/j.annonc.2020.11.023] [Cited by in Crossref: 19] [Cited by in F6Publishing: 8] [Article Influence: 9.5] [Reference Citation Analysis]
|
| 80 |
Kentley J, Allawh R, Rao S, Doyle A, Ahmad A, Nadhan K, Proby C, Harwood CA, Chung CL. The burden of cutaneous disease in solid organ transplant recipients of color. Am J Transplant 2021;21:1215-26. [PMID: 32659869 DOI: 10.1111/ajt.16210] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
|
| 81 |
Gravemeyer J, Lange A, Ritter C, Spassova I, Song L, Picard D, Remke M, Horny K, Sriram A, Gambichler T, Schadendorf D, Hoffmann D, Becker JC. Classical and Variant Merkel Cell Carcinoma Cell Lines Display Different Degrees of Neuroendocrine Differentiation and Epithelial-Mesenchymal Transition. J Invest Dermatol 2021;141:1675-1686.e4. [PMID: 33600825 DOI: 10.1016/j.jid.2021.01.012] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 82 |
Mäki-Nevala S, Ukwattage S, Olkinuora A, Almusa H, Ahtiainen M, Ristimäki A, Seppälä T, Lepistö A, Mecklin JP, Peltomäki P. Somatic mutation profiles as molecular classifiers of ulcerative colitis-associated colorectal cancer. Int J Cancer 2021;148:2997-3007. [PMID: 33521965 DOI: 10.1002/ijc.33492] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 83 |
Fania L, Didona D, Di Pietro FR, Verkhovskaia S, Morese R, Paolino G, Donati M, Ricci F, Coco V, Ricci F, Candi E, Abeni D, Dellambra E. Cutaneous Squamous Cell Carcinoma: From Pathophysiology to Novel Therapeutic Approaches. Biomedicines 2021;9:171. [PMID: 33572373 DOI: 10.3390/biomedicines9020171] [Cited by in Crossref: 27] [Cited by in F6Publishing: 36] [Article Influence: 13.5] [Reference Citation Analysis]
|
| 84 |
Ostrowski SM, Fisher DE. Biology of Melanoma. Hematology/Oncology Clinics of North America 2021;35:29-56. [DOI: 10.1016/j.hoc.2020.08.010] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 6.5] [Reference Citation Analysis]
|
| 85 |
Thomson J, Bewicke-Copley F, Anene CA, Gulati A, Nagano A, Purdie K, Inman GJ, Proby CM, Leigh IM, Harwood CA, Wang J. The Genomic Landscape of Actinic Keratosis. J Invest Dermatol 2021;141:1664-1674.e7. [PMID: 33482222 DOI: 10.1016/j.jid.2020.12.024] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 5.0] [Reference Citation Analysis]
|
| 86 |
Mengoni M, Tüting T, Gaffal E. [Photocarcinogenesis-molecular mechanisms and practical relevance]. Hautarzt 2021;72:6-13. [PMID: 33289852 DOI: 10.1007/s00105-020-04736-7] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 87 |
Poojan S, Pandey R. Cancer of the Skin: Types and Etiology. Skin Cancer: Pathogenesis and Diagnosis 2021. [DOI: 10.1007/978-981-16-0364-8_1] [Reference Citation Analysis]
|
| 88 |
Strickley JD, Messerschmidt JL, Jenson AB, Joh J, Demehri S. Reply to: Beta human papillomaviruses and skin cancer. Nature 2020;588:E22-3. [PMID: 33328662 DOI: 10.1038/s41586-020-3024-z] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
|
| 89 |
Perry J, Ashford B, Thind AS, Gauthier ME, Minaei E, Major G, Iyer NG, Gupta R, Clark J, Ranson M. Comprehensive Mutational and Phenotypic Characterization of New Metastatic Cutaneous Squamous Cell Carcinoma Cell Lines Reveal Novel Drug Susceptibilities. Int J Mol Sci 2020;21:E9536. [PMID: 33333825 DOI: 10.3390/ijms21249536] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.7] [Reference Citation Analysis]
|
| 90 |
Hussein D, Dallol A, Quintas R, Schulten HJ, Alomari M, Baeesa S, Bangash M, Alghamdi F, Khan I, ElAssouli MM, Saka M, Carracedo A, Chaudhary A, Abuzenadah A. Overlapping variants in the blood, tissues and cell lines for patients with intracranial meningiomas are predominant in stem cell-related genes. Heliyon 2020;6:e05632. [PMID: 33305042 DOI: 10.1016/j.heliyon.2020.e05632] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 91 |
Krishnamurthy K, Lindsey AM, Estrada CA, Martinez CC, Cusnir M, Schwartz M, Sriganeshan V, Poppiti R. Title- Genomic landscape of squamous cell carcinoma- Different genetic pathways culminating in a common phenotype. Cancer Treat Res Commun 2020;25:100238. [PMID: 33260028 DOI: 10.1016/j.ctarc.2020.100238] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 92 |
Lazo de la Vega L, Bick N, Hu K, Rahrig SE, Silva CD, Matayoshi S, Picciarelli P, Wang X, Sugar A, Soong HK, Mian SI, Robinson DR, Chinnaiyan AM, Demirci H, Daniels AB, Worden F, Eberhart CG, Tomlins SA, Rao RC, Harms PW. Invasive squamous cell carcinomas and precursor lesions on UV-exposed epithelia demonstrate concordant genomic complexity in driver genes. Mod Pathol 2020;33:2280-94. [PMID: 32461624 DOI: 10.1038/s41379-020-0571-7] [Cited by in Crossref: 20] [Cited by in F6Publishing: 20] [Article Influence: 6.7] [Reference Citation Analysis]
|
| 93 |
Newell F, Wilmott JS, Johansson PA, Nones K, Addala V, Mukhopadhyay P, Broit N, Amato CM, Van Gulick R, Kazakoff SH, Patch AM, Koufariotis LT, Lakis V, Leonard C, Wood S, Holmes O, Xu Q, Lewis K, Medina T, Gonzalez R, Saw RPM, Spillane AJ, Stretch JR, Rawson RV, Ferguson PM, Dodds TJ, Thompson JF, Long GV, Levesque MP, Robinson WA, Pearson JV, Mann GJ, Scolyer RA, Waddell N, Hayward NK. Whole-genome sequencing of acral melanoma reveals genomic complexity and diversity. Nat Commun 2020;11:5259. [PMID: 33067454 DOI: 10.1038/s41467-020-18988-3] [Cited by in Crossref: 49] [Cited by in F6Publishing: 53] [Article Influence: 16.3] [Reference Citation Analysis]
|
| 94 |
Dayal JHS, Mason SM, Salas-Alanis JC, McGrath JA, Taylor RG, Mellerio JE, Blyth K, South AP, Inman GJ. Heterogeneous addiction to transforming growth factor-beta signalling in recessive dystrophic epidermolysis bullosa-associated cutaneous squamous cell carcinoma. Br J Dermatol 2021;184:697-708. [PMID: 32726455 DOI: 10.1111/bjd.19421] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
|
| 95 |
Li H, Brakebusch C. Analyzing skin tumor development in mice by the DMBA/TPA model. Methods Cell Biol 2021;163:113-21. [PMID: 33785160 DOI: 10.1016/bs.mcb.2020.08.004] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 96 |
Loureiro JB, Abrantes M, Oliveira PA, Saraiva L. P53 in skin cancer: From a master player to a privileged target for prevention and therapy. Biochim Biophys Acta Rev Cancer 2020;1874:188438. [PMID: 32980466 DOI: 10.1016/j.bbcan.2020.188438] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 5.3] [Reference Citation Analysis]
|
| 97 |
Shapanis A, Lai C, Smith S, Coltart G, Sommerlad M, Schofield J, Parkinson E, Skipp P, Healy E. Identification of proteins associated with development of metastasis from cutaneous squamous cell carcinomas (cSCCs) via proteomic analysis of primary cSCCs. Br J Dermatol 2021;184:709-21. [PMID: 32794257 DOI: 10.1111/bjd.19485] [Cited by in Crossref: 10] [Cited by in F6Publishing: 12] [Article Influence: 3.3] [Reference Citation Analysis]
|
| 98 |
Mulvaney PM, Schmults CD. Molecular prediction of metastasis in cutaneous squamous cell carcinoma. Curr Opin Oncol 2020;32:129-36. [PMID: 31850970 DOI: 10.1097/CCO.0000000000000609] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.7] [Reference Citation Analysis]
|
| 99 |
Riihilä P, Nissinen L, Kähäri VM. Matrix metalloproteinases in keratinocyte carcinomas. Exp Dermatol 2021;30:50-61. [PMID: 32869366 DOI: 10.1111/exd.14183] [Cited by in Crossref: 12] [Cited by in F6Publishing: 14] [Article Influence: 4.0] [Reference Citation Analysis]
|
| 100 |
Pan L, Lemieux ME, Thomas T, Rogers JM, Lipper CH, Lee W, Johnson C, Sholl LM, South AP, Marto JA, Adelmant GO, Blacklow SC, Aster JC. IER5, a DNA damage response gene, is required for Notch-mediated induction of squamous cell differentiation. Elife 2020;9:e58081. [PMID: 32936072 DOI: 10.7554/eLife.58081] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 2.7] [Reference Citation Analysis]
|
| 101 |
Garofoli M, Volpicella M, Guida M, Porcelli L, Azzariti A. The Role of Non-Coding RNAs as Prognostic Factor, Predictor of Drug Response or Resistance and Pharmacological Targets, in the Cutaneous Squamous Cell Carcinoma. Cancers (Basel) 2020;12:E2552. [PMID: 32911687 DOI: 10.3390/cancers12092552] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 102 |
Stark MS, Tell-Martí G, Martins da Silva V, Martinez-Barrios E, Calbet-Llopart N, Vicente A, Sturm RA, Soyer HP, Puig S, Malvehy J, Carrera C, Puig-Butillé JA. The Distinctive Genomic Landscape of Giant Congenital Melanocytic Nevi. J Invest Dermatol 2021;141:692-695.e2. [PMID: 32800874 DOI: 10.1016/j.jid.2020.07.022] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
|
| 103 |
Mack CL, Adams D, Assis DN, Kerkar N, Manns MP, Mayo MJ, Vierling JM, Alsawas M, Murad MH, Czaja AJ. Diagnosis and Management of Autoimmune Hepatitis in Adults and Children: 2019 Practice Guidance and Guidelines From the American Association for the Study of Liver Diseases. Hepatology 2020;72:671-722. [PMID: 31863477 DOI: 10.1002/hep.31065] [Cited by in Crossref: 282] [Cited by in F6Publishing: 295] [Article Influence: 94.0] [Reference Citation Analysis]
|
| 104 |
Yu NY, DeWees TA, Alam M, Ochoa SA, Mangold AR, Steidley DE, Vargas HE, Golafshar MA, Schild SE, Halyard MY, Patel SH. Risk of Recurrence and 10-Year Outcomes in Surgically Treated Nonmelanoma Skin Cancer in Cardiac and Liver Transplant Recipients. Am J Clin Oncol 2020;43:366-70. [PMID: 32217856 DOI: 10.1097/COC.0000000000000677] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 105 |
Cives M, Mannavola F, Lospalluti L, Sergi MC, Cazzato G, Filoni E, Cavallo F, Giudice G, Stucci LS, Porta C, Tucci M. Non-Melanoma Skin Cancers: Biological and Clinical Features. Int J Mol Sci 2020;21:E5394. [PMID: 32751327 DOI: 10.3390/ijms21155394] [Cited by in Crossref: 50] [Cited by in F6Publishing: 51] [Article Influence: 16.7] [Reference Citation Analysis]
|
| 106 |
Derynck R, Turley SJ, Akhurst RJ. TGFβ biology in cancer progression and immunotherapy. Nat Rev Clin Oncol 2021;18:9-34. [DOI: 10.1038/s41571-020-0403-1] [Cited by in Crossref: 188] [Cited by in F6Publishing: 199] [Article Influence: 62.7] [Reference Citation Analysis]
|
| 107 |
Lazar AD, Dinescu S, Costache M. Deciphering the Molecular Landscape of Cutaneous Squamous Cell Carcinoma for Better Diagnosis and Treatment. J Clin Med 2020;9:E2228. [PMID: 32674318 DOI: 10.3390/jcm9072228] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 2.3] [Reference Citation Analysis]
|
| 108 |
Dotimas J, Das M, Martin D. Cutaneous T-cell lymphoma in the setting of anti-tumor necrosis factor and immunomodulator therapy: A case report and literature review. SAGE Open Med Case Rep 2020;8:2050313X20937223. [PMID: 32655868 DOI: 10.1177/2050313X20937223] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
|
| 109 |
Fujimura T, Kambayashi Y, Tono H, Lyu C, Ohuchi K, Hashimoto A, Aiba S. Successful treatment of unresectable recurrent cutaneous squamous cell carcinoma of the scalp with meningeal invasion with nivolumab monotherapy. Dermatologic Therapy 2020;33. [DOI: 10.1111/dth.13672] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 110 |
Leigh IM. Advanced cutaneous squamous cell carcinoma - a pressing case for treatment. J Eur Acad Dermatol Venereol 2019;33 Suppl 8:3-5. [PMID: 31833611 DOI: 10.1111/jdv.15841] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
|
| 111 |
Traeger L, Raju D. Metastatic squamous cell carcinoma presenting as an ileocolonic fistula. ANZ J Surg 2021;91:200-2. [PMID: 32497387 DOI: 10.1111/ans.16058] [Reference Citation Analysis]
|
| 112 |
Lobl MB, Clarey D, Higgins S, Sutton A, Hansen L, Wysong A. Targeted next-generation sequencing of matched localized and metastatic primary high-risk SCCs identifies driver and co-occurring mutations and novel therapeutic targets. J Dermatol Sci 2020;99:30-43. [PMID: 32595073 DOI: 10.1016/j.jdermsci.2020.05.007] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 113 |
Piipponen M, Nissinen L, Kähäri VM. Long non-coding RNAs in cutaneous biology and keratinocyte carcinomas. Cell Mol Life Sci 2020;77:4601-14. [PMID: 32462404 DOI: 10.1007/s00018-020-03554-3] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 114 |
Pan L, Lemieux ME, Thomas T, Rogers JM, Lee W, Johnson C, Sholl L, South AP, Marto JA, Adelmant GO, Blacklow SC, Aster JC. IER5, a DNA-damage response gene, is required for Notch-mediated induction of squamous cell differentiation.. [DOI: 10.1101/2020.04.21.051730] [Reference Citation Analysis]
|
| 115 |
Gualandi M, Iorio M, Engeler O, Serra-Roma A, Gasparre G, Schulte JH, Hohl D, Shakhova O. Oncogenic ALK F1174L drives tumorigenesis in cutaneous squamous cell carcinoma. Life Sci Alliance 2020;3:e201900601. [PMID: 32312912 DOI: 10.26508/lsa.201900601] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 116 |
Corchado-Cobos R, García-Sancha N, González-Sarmiento R, Pérez-Losada J, Cañueto J. Cutaneous Squamous Cell Carcinoma: From Biology to Therapy. Int J Mol Sci 2020;21:E2956. [PMID: 32331425 DOI: 10.3390/ijms21082956] [Cited by in Crossref: 42] [Cited by in F6Publishing: 47] [Article Influence: 14.0] [Reference Citation Analysis]
|
| 117 |
Pfeifer GP. Mechanisms of UV-induced mutations and skin cancer. Genome Instab Dis 2020;1:99-113. [PMID: 34589668 DOI: 10.1007/s42764-020-00009-8] [Cited by in Crossref: 20] [Cited by in F6Publishing: 13] [Article Influence: 6.7] [Reference Citation Analysis]
|
| 118 |
Guerrero-Aspizua S, González-Masa A, Conti CJ, García M, Chacón-Solano E, Larcher F, Del Río M. Humanization of Tumor Stroma by Tissue Engineering as a Tool to Improve Squamous Cell Carcinoma Xenograft. Int J Mol Sci 2020;21:E1951. [PMID: 32178458 DOI: 10.3390/ijms21061951] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
|
| 119 |
Shtraichman O, Ahya VN. Malignancy after lung transplantation. Ann Transl Med 2020;8:416. [PMID: 32355860 DOI: 10.21037/atm.2020.02.126] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 3.7] [Reference Citation Analysis]
|
| 120 |
Stratigos AJ, Garbe C, Dessinioti C, Lebbe C, Bataille V, Bastholt L, Dreno B, Fargnoli MC, Forsea AM, Frenard C, Harwood CΑ, Hauschild A, Hoeller C, Kandolf-Sekulovic L, Kaufmann R, Kelleners-Smeets NW, Malvehy J, Del Marmol V, Middleton MR, Moreno-Ramirez D, Pellecani G, Peris K, Saiag P, van den Beuken-van Everdingen MHJ, Vieira R, Zalaudek I, Eggermont AMM, Grob JJ; European Dermatology Forum (EDF), the European Association of Dermato-Oncology (EADO) and the European Organization for Research and Treatment of Cancer (EORTC). European interdisciplinary guideline on invasive squamous cell carcinoma of the skin: Part 1. epidemiology, diagnostics and prevention. Eur J Cancer 2020;128:60-82. [PMID: 32113941 DOI: 10.1016/j.ejca.2020.01.007] [Cited by in Crossref: 70] [Cited by in F6Publishing: 81] [Article Influence: 23.3] [Reference Citation Analysis]
|
| 121 |
Bibee K, Swartz A, Sridharan S, Kurten CHL, Wessel CB, Skinner H, Zandberg DP. Cutaneous squamous cell carcinoma in the organ transplant recipient. Oral Oncol 2020;103:104562. [PMID: 32065978 DOI: 10.1016/j.oraloncology.2019.104562] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
|
| 122 |
Di Nardo L, Pellegrini C, Di Stefani A, Del Regno L, Sollena P, Piccerillo A, Longo C, Garbe C, Fargnoli MC, Peris K. Molecular genetics of cutaneous squamous cell carcinoma: perspective for treatment strategies. J Eur Acad Dermatol Venereol 2020;34:932-41. [PMID: 31747091 DOI: 10.1111/jdv.16098] [Cited by in Crossref: 19] [Cited by in F6Publishing: 20] [Article Influence: 6.3] [Reference Citation Analysis]
|
| 123 |
Hayes MD, Ward S, Crawford G, Seoane RC, Jackson WD, Kipling D, Voehringer D, Dunn-Walters D, Strid J. Inflammation-induced IgE promotes epithelial hyperplasia and tumour growth. Elife 2020;9:e51862. [PMID: 31931959 DOI: 10.7554/eLife.51862] [Cited by in Crossref: 25] [Cited by in F6Publishing: 25] [Article Influence: 8.3] [Reference Citation Analysis]
|
| 124 |
Tonolli PN, Teixeira Tasso T, S. Baptista M. Nanocosmetics for broadband light protection sun care products. Nanocosmetics 2020. [DOI: 10.1016/b978-0-12-822286-7.00008-5] [Reference Citation Analysis]
|
| 125 |
Boeckmann L, Martens MC, Emmert S. Molecular Biology of Basal and Squamous Cell Carcinomas. Adv Exp Med Biol 2020;1268:171-91. [PMID: 32918219 DOI: 10.1007/978-3-030-46227-7_9] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
|
| 126 |
Hervás-Marín D, Higgins F, Sanmartín O, López-Guerrero JA, Bañó MC, Igual JC, Quilis I, Sandoval J. Genome wide DNA methylation profiling identifies specific epigenetic features in high-risk cutaneous squamous cell carcinoma. PLoS One 2019;14:e0223341. [PMID: 31860637 DOI: 10.1371/journal.pone.0223341] [Cited by in Crossref: 20] [Cited by in F6Publishing: 22] [Article Influence: 5.0] [Reference Citation Analysis]
|
| 127 |
Osorio FG, Rosendahl Huber A, Oka R, Verheul M, Patel SH, Hasaart K, de la Fonteijne L, Varela I, Camargo FD, van Boxtel R. Somatic Mutations Reveal Lineage Relationships and Age-Related Mutagenesis in Human Hematopoiesis. Cell Rep 2018;25:2308-2316.e4. [PMID: 30485801 DOI: 10.1016/j.celrep.2018.11.014] [Cited by in Crossref: 117] [Cited by in F6Publishing: 123] [Article Influence: 29.3] [Reference Citation Analysis]
|
| 128 |
Engels EA. Epidemiologic perspectives on immunosuppressed populations and the immunosurveillance and immunocontainment of cancer. Am J Transplant 2019;19:3223-32. [PMID: 31206226 DOI: 10.1111/ajt.15495] [Cited by in Crossref: 23] [Cited by in F6Publishing: 23] [Article Influence: 5.8] [Reference Citation Analysis]
|
| 129 |
Hooiveld-noeken J, Fehrmann R, de Vries E, Jalving M. Driving innovation for rare skin cancers: utilizing common tumours and machine learning to predict immune checkpoint inhibitor response. Immuno-Oncology Technology 2019;4:1-7. [DOI: 10.1016/j.iotech.2019.11.002] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 130 |
McCabe MJ, Gauthier MA, Chan CL, Thompson TJ, De Sousa SMC, Puttick C, Grady JP, Gayevskiy V, Tao J, Ying K, Cipponi A, Deng N, Swarbrick A, Thomas ML, Lord RV, Johns AL, Kohonen-Corish M, O'Toole SA, Clark J, Mueller SA, Gupta R, McCormack AI, Dinger ME, Cowley MJ; kConFab. Development and validation of a targeted gene sequencing panel for application to disparate cancers. Sci Rep 2019;9:17052. [PMID: 31745186 DOI: 10.1038/s41598-019-52000-3] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 131 |
Condorelli AG, Dellambra E, Logli E, Zambruno G, Castiglia D. Epidermolysis Bullosa-Associated Squamous Cell Carcinoma: From Pathogenesis to Therapeutic Perspectives. Int J Mol Sci 2019;20:E5707. [PMID: 31739489 DOI: 10.3390/ijms20225707] [Cited by in Crossref: 47] [Cited by in F6Publishing: 47] [Article Influence: 11.8] [Reference Citation Analysis]
|
| 132 |
McHugh A, Fernandes K, Chinner N, Ibrahim AFM, Garg AK, Boag G, Hepburn LA, Proby CM, Leigh IM, Saville MK. The Identification of Potential Therapeutic Targets for Cutaneous Squamous Cell Carcinoma. J Invest Dermatol 2020;140:1154-1165.e5. [PMID: 31705877 DOI: 10.1016/j.jid.2019.09.024] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]
|
| 133 |
Kervarrec T, Tallet A, Miquelestorena-Standley E, Houben R, Schrama D, Gambichler T, Berthon P, Le Corre Y, Hainaut-Wierzbicka E, Aubin F, Bens G, Tabareau-Delalande F, Beneton N, Fromont G, Arbion F, Leteurtre E, Herfs M, Touzé A, Samimi M, Guyétant S. Morphologic and immunophenotypical features distinguishing Merkel cell polyomavirus-positive and negative Merkel cell carcinoma. Mod Pathol 2019;32:1605-16. [PMID: 31201352 DOI: 10.1038/s41379-019-0288-7] [Cited by in Crossref: 26] [Cited by in F6Publishing: 27] [Article Influence: 6.5] [Reference Citation Analysis]
|
| 134 |
Hayes MD, Ward S, Crawford G, Seoane RC, Jackson WD, Kipling D, Voehringer D, Dunn-walters D, Strid J. Natural IgE promotes epithelial hyperplasia and inflammation-driven tumour growth.. [DOI: 10.1101/782805] [Reference Citation Analysis]
|
| 135 |
Hervás-marín D, Higgins F, Sanmartín O, López-guerrero JA, Bañó MC, Igual JC, Quilis I, Sandoval J. Genome wide DNA methylation profiling identifies specific epigenetic features in high-risk cutaneous squamous cell carcinoma.. [DOI: 10.1101/777227] [Reference Citation Analysis]
|
| 136 |
Conforti C, Corneli P, Harwood C, Zalaudek I. Evolving Role of Systemic Therapies in Non-melanoma Skin Cancer. Clin Oncol (R Coll Radiol) 2019;31:759-68. [PMID: 31522944 DOI: 10.1016/j.clon.2019.08.011] [Cited by in Crossref: 20] [Cited by in F6Publishing: 20] [Article Influence: 5.0] [Reference Citation Analysis]
|
| 137 |
Lang CMR, Chan CK, Veltri A, Lien WH. Wnt Signaling Pathways in Keratinocyte Carcinomas. Cancers (Basel) 2019;11:E1216. [PMID: 31438551 DOI: 10.3390/cancers11091216] [Cited by in Crossref: 14] [Cited by in F6Publishing: 17] [Article Influence: 3.5] [Reference Citation Analysis]
|
| 138 |
Robinson DJ, Patel A, Purdie KJ, Wang J, Rizvi H, Hufbauer M, Ostano P, Akgül B, Chiorino G, Harwood CA, Bergamaschi D. Epigenetic Regulation of iASPP-p63 Feedback Loop in Cutaneous Squamous Cell Carcinoma. Journal of Investigative Dermatology 2019;139:1658-1671.e8. [DOI: 10.1016/j.jid.2019.01.020] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 2.3] [Reference Citation Analysis]
|
| 139 |
Kambayashi Y, Fujimura T, Hidaka T, Aiba S. Biomarkers for Predicting Efficacies of Anti-PD1 Antibodies. Front Med (Lausanne) 2019;6:174. [PMID: 31417907 DOI: 10.3389/fmed.2019.00174] [Cited by in Crossref: 27] [Cited by in F6Publishing: 30] [Article Influence: 6.8] [Reference Citation Analysis]
|
| 140 |
Riihilä P, Nissinen L, Knuutila J, Rahmati Nezhad P, Viiklepp K, Kähäri VM. Complement System in Cutaneous Squamous Cell Carcinoma. Int J Mol Sci 2019;20:E3550. [PMID: 31331124 DOI: 10.3390/ijms20143550] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 3.5] [Reference Citation Analysis]
|
| 141 |
Zilberg C, Lee MW, Kraitsek S, Ashford B, Ranson M, Shannon K, Iyer NG, Ch'ng S, Low TH, Palme C, Clark J, Gupta R, Yu B. Is high-risk cutaneous squamous cell carcinoma of the head and neck a suitable candidate for current targeted therapies? J Clin Pathol 2020;73:17-22. [PMID: 31300530 DOI: 10.1136/jclinpath-2019-206038] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 142 |
Hassan S, Purdie KJ, Wang J, Harwood CA, Proby CM, Pourreyron C, Mladkova N, Nagano A, Dhayade S, Athineos D, Caley M, Mannella V, Blyth K, Inman GJ, Leigh IM. A Unique Panel of Patient-Derived Cutaneous Squamous Cell Carcinoma Cell Lines Provides a Preclinical Pathway for Therapeutic Testing. Int J Mol Sci 2019;20:E3428. [PMID: 31336867 DOI: 10.3390/ijms20143428] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 2.3] [Reference Citation Analysis]
|
| 143 |
Trevino V. Integrative genomic analysis identifies associations of molecular alterations to APOBEC and BRCA1/2 mutational signatures in breast cancer. Mol Genet Genomic Med 2019;7:e810. [PMID: 31294536 DOI: 10.1002/mgg3.810] [Cited by in Crossref: 2] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 144 |
Maura F, Degasperi A, Nadeu F, Leongamornlert D, Davies H, Moore L, Royo R, Ziccheddu B, Puente XS, Avet-Loiseau H, Campbell PJ, Nik-Zainal S, Campo E, Munshi N, Bolli N. A practical guide for mutational signature analysis in hematological malignancies. Nat Commun 2019;10:2969. [PMID: 31278357 DOI: 10.1038/s41467-019-11037-8] [Cited by in Crossref: 90] [Cited by in F6Publishing: 101] [Article Influence: 22.5] [Reference Citation Analysis]
|
| 145 |
Mueller SA, Gauthier MA, Ashford B, Gupta R, Gayevskiy V, Ch’ng S, Palme CE, Shannon K, Clark JR, Ranson M, Cowley MJ. Mutational Patterns in Metastatic Cutaneous Squamous Cell Carcinoma. Journal of Investigative Dermatology 2019;139:1449-1458.e1. [DOI: 10.1016/j.jid.2019.01.008] [Cited by in Crossref: 27] [Cited by in F6Publishing: 28] [Article Influence: 6.8] [Reference Citation Analysis]
|
| 146 |
Grolleman JE, Díaz-Gay M, Franch-Expósito S, Castellví-Bel S, de Voer RM. Somatic mutational signatures in polyposis and colorectal cancer. Mol Aspects Med 2019;69:62-72. [PMID: 31108140 DOI: 10.1016/j.mam.2019.05.002] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 2.8] [Reference Citation Analysis]
|
| 147 |
Leigh IM, Proby CM, Inman GJ, Harwood CA. Azathioprine: friend or foe? Br J Dermatol 2019;180:961-3. [PMID: 31025740 DOI: 10.1111/bjd.17345] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 148 |
Bottomley MJ, Thomson J, Harwood C, Leigh I. The Role of the Immune System in Cutaneous Squamous Cell Carcinoma. Int J Mol Sci 2019;20:E2009. [PMID: 31022866 DOI: 10.3390/ijms20082009] [Cited by in Crossref: 50] [Cited by in F6Publishing: 57] [Article Influence: 12.5] [Reference Citation Analysis]
|
| 149 |
Cangemi M, Montico B, Faè DA, Steffan A, Dolcetti R. Dissecting the Multiplicity of Immune Effects of Immunosuppressive Drugs to Better Predict the Risk of de novo Malignancies in Solid Organ Transplant Patients. Front Oncol 2019;9:160. [PMID: 30972289 DOI: 10.3389/fonc.2019.00160] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 2.5] [Reference Citation Analysis]
|
| 150 |
Gallant JN, Sewell A, Almodovar K, Wang Q, Dahlman KB, Abramson RG, Kapp ME, Brown BT, Boyd KL, Gilbert J, Cohen DN, Yarbrough WG, Zhao Z, Lovly CM. Genomic landscape of a metastatic malignant proliferating tricholemmal tumor and its response to PI3K inhibition. NPJ Precis Oncol 2019;3:5. [PMID: 30793038 DOI: 10.1038/s41698-019-0077-2] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]
|
| 151 |
Nagarajan P, Asgari MM, Green AC, Guhan SM, Arron ST, Proby CM, Rollison DE, Harwood CA, Toland AE. Keratinocyte Carcinomas: Current Concepts and Future Research Priorities. Clin Cancer Res 2019;25:2379-91. [PMID: 30523023 DOI: 10.1158/1078-0432.CCR-18-1122] [Cited by in Crossref: 62] [Cited by in F6Publishing: 65] [Article Influence: 12.4] [Reference Citation Analysis]
|
| 152 |
Welyczko N. Journal Scan. Gastrointestinal Nursing 2018;16:12-14. [DOI: 10.12968/gasn.2018.16.9.12] [Reference Citation Analysis]
|
| 153 |
[DOI: 10.1101/2020.12.13.422581] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
|
